Literature DB >> 2276818

Long-term persistence of specific T- and B-lymphocyte responses to Borrelia burgdorferi following untreated neuroborreliosis.

H Krüger1, M Pulz, R Martin, V Sticht-Groh.   

Abstract

Follow-up studies on 56 patients who suffered from antibiotically untreated, acute, monophasic neuroborreliosis five to 23 years ago revealed significant positive levels of IgG antibodies to Borrelia burgdorferi (Bb) in the serum and cerebrospinal fluid (CSF) of 20 patients (IFT, ELISA, Bb-specific IgG Western blot, Bb-specific IEF-IgG immunoblot). Nine of 10 tested patients had a definitely positive T-cell proliferative response to whole B. burgdorferi, with a mean (+/- -SEM) stimulation index of 7.2 +/- 1.8. Because the patients studied exhibited no, or only mild to medium sequelae without any evidence of a chronic-progressive disease, we interpret the long-term persistence of specific T- and B-lymphocyte responses to B. burgdorferi as an "immunological scar syndrome". Finally, diagnostic criteria of active neuroborreliosis are proposed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276818     DOI: 10.1007/bf01646998

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  24 in total

1.  The Oslo study of untreated syphilis; an epidemiologic investigation of the natural course of the syphilitic infection based upon a re-study of the Boeck-Bruusgaard material.

Authors:  T Gjestland
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1955

2.  [Lyme disease from the neurologist's viewpoint].

Authors:  P E Hänny; H J Häuselmann
Journal:  Schweiz Med Wochenschr       Date:  1987-06-13

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Nervous system abnormalities in Lyme disease.

Authors:  J J Halperin; H L Pass; A K Anand; B J Luft; D J Volkman; R J Dattwyler
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

5.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

6.  Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome).

Authors:  A Henriksson; H Link; M Cruz; G Stiernstedt
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

7.  Focal encephalitis in a young woman 6 years after the onset of Lyme disease: tertiary Lyme disease?

Authors:  J P Broderick; B A Sandok; L E Mertz
Journal:  Mayo Clin Proc       Date:  1987-04       Impact factor: 7.616

8.  Clonal expansion and functional analysis of virus-specific T lymphocytes from cerebrospinal fluid in measles encephalitis.

Authors:  B Fleischer; H W Kreth
Journal:  Hum Immunol       Date:  1983-08       Impact factor: 2.850

9.  Lyme meningoencephalitis: report of a severe, penicillin-resistant case.

Authors:  M N Diringer; J J Halperin; R J Dattwyler
Journal:  Arthritis Rheum       Date:  1987-06

10.  Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth).

Authors:  R Ackermann; P Hörstrup; R Schmidt
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  3 in total

1.  Relationship between the Borrelia burgdorferi specific immune response and different stages and syndromes in neuroborreliosis.

Authors:  P Oschmann; H J Wellensiek; W Zhong; W Dorndorf; K W Pflughaupt
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

Review 2.  Neurological manifestations of Lyme borreliosis.

Authors:  W Kristoferitsch
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

3.  Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases.

Authors:  H Krüger; E Heim; B Schuknecht; S Scholz
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.